These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34260975)

  • 1. Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease.
    Vedel-Krogh S; Nielsen SF; Nordestgaard BG; Lange P; Vestbo J
    Respir Med; 2021 Sep; 186():106529. PubMed ID: 34260975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ; Fu JJ; McDonald VM; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of COPD depends on severity of exacerbation history: A population-based analysis.
    Çolak Y; Afzal S; Marott JL; Nordestgaard BG; Vestbo J; Ingebrigtsen TS; Lange P
    Respir Med; 2019 Aug; 155():141-147. PubMed ID: 31362177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
    Fu JJ; McDonald VM; Baines KJ; Gibson PG
    Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Lange P; Nordestgaard BG
    Int J Epidemiol; 2016 Oct; 45(5):1551-1559. PubMed ID: 27118560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.
    Oshagbemi OA; Keene SJ; Driessen JHM; Jordan R; Wouters EFM; de Boer A; de Vries F; Franssen FME
    Respir Med; 2018 Nov; 144():1-6. PubMed ID: 30366578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2016; 4(2):273-83.e5. PubMed ID: 26619923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
    Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.
    Hiles SA; Gibson PG; McDonald VM
    Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?
    Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Paillasseur JL; Pinet C; Jebrak G; Roche N;
    Allergy; 2017 Jan; 72(1):137-145. PubMed ID: 27501862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.